The deadly coronavirus is shaking the world in a horrible manner and everyone is expecting an vaccine as early as possible. This month seems to give positive hope, as for the second time this month, COVID-19 vaccine candidate, Moderna has given a promising news. It has said on Monday that its shots provide strong protection, a dash of hope against the grim backdrop of coronavirus surges in the U.S. and around the world. Moderna said its vaccine appears to be 94.5% effective, according to preliminary data from the company’s still ongoing study.

Moderna's competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective, a week ago. It makes both the companies on track to seek permission within weeks for emergency use in the U.S. Dr. Stephen Hoge, Moderna’s president, said, “That should give us all hope that actually a vaccine is going to be able to stop this pandemic and hopefully get us back to our lives". He added, “It won’t be Moderna alone that solves this problem. It’s going to require many vaccines to meet the global demand". 

Moderna’s vaccine has been created with the National Institutes of Health,is under study with 30,000 volunteers who received either the real vaccination or a dummy shot. On Sunday, an independent monitoring board broke the code to examine 95 infections that were recorded starting two weeks after volunteers' second dose and the board discovered all but five illnesses occurred in participants who got the placebo. The study is still continuing. 

'Life will be normal till next year' claims Scientist who made '90% successful vaccine'

Johnson&Johnson starts 2-dose trial of its COVID-19 vaccine

Serum Institute CEO claims India Will Get 100 mn Oxford Vaccine Shots By December